International Laboratories, Inc. has recalled 22,455 cartons of Pravastatin Sodium (USP) 10 mg and 20 mg tablets because some bottles may contain both dosages in the same container. This medication is used to treat high cholesterol and prevent cardiovascular disease. The recall affects 30-count bottles sold nationwide between 2018 and 2019, potentially leading to patients taking double or half of their prescribed dose. Consumers should consult their healthcare provider to discuss their treatment and how to identify the correct tablets.
Taking the 20 mg tablet instead of the 10 mg tablet could lead to an unintended higher dose, increasing the risk of side effects like muscle pain or liver issues, while taking a 10 mg tablet instead of a 20 mg tablet could result in under-treatment of cholesterol levels.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.